Is pathogenic humoral autoimmunity a Th1 response?

[1]  H. Link,et al.  Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats , 1996, European journal of immunology.

[2]  M. Scaff,et al.  Acetylcholine receptor antibody in myasthenia gravis , 1989, Acta neurologica Scandinavica.

[3]  N. Sarvetnick,et al.  Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis. , 2000, Immunology today.

[4]  H. Bazin,et al.  Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. , 1978, Immunochemistry.

[5]  H. Link,et al.  Cytokines and the pathogenesis of myasthenia gravis , 1997, Muscle & nerve.

[6]  T. Olsson,et al.  Suppression of Experimental Autoimmune Myasthenia Gravis After CD8 Depletion is Associated with Decreased IFN‐γ and IL‐4 , 1995, Scandinavian journal of immunology.

[7]  P. Christadoss.  C5 gene influences the development of murine myasthenia gravis. , 1988, Journal of immunology.

[8]  F. Shi,et al.  Cellular mRNA expression of interferon‐gamma (IFN‐γ), IL‐4 and IL‐10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats , 1997, Clinical and experimental immunology.

[9]  S. Gammeltoft,et al.  Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. , 1987, Clinical and experimental immunology.

[10]  R. Pirskanen,et al.  Acetylcholine receptor-reactive T cells in myasthenia gravis: Evidence for the involvement of different subpopulations of T helper cells , 1994, Journal of Neuroimmunology.

[11]  G. Biesecker,et al.  Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. , 1989, Journal of immunology.

[12]  T. Olsson,et al.  Mucosal Tolerance to Experimental Autoimmune Myasthenia Gravis Is Associated with Down‐regulation of AChR‐specific IFN‐γ‐expressing Th1‐like Cells and Up‐regulation of TGF‐β mRNA in Mononuclear Cells , 1996, Annals of the New York Academy of Sciences.

[13]  R. Ulevitch,et al.  Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis , 1978, The Journal of experimental medicine.

[14]  I. Bernard,et al.  Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. , 1999, Journal of immunology.

[15]  G. Comi,et al.  IL‐12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody‐ mediated disease , 1998, European journal of immunology.

[16]  T. Olsson,et al.  Organ‐specific autoantigens induce interferon‐γ and interleukin‐4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis , 1994, Neurology.

[17]  P. Christadoss.  Immunogenetics of experimental autoimmune myasthenia gravis. , 1989, Critical reviews in immunology.